Stay updated on SRA737 Combo with Gem/Cisplatin: Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the SRA737 Combo with Gem/Cisplatin: Advanced Cancer Clinical Trial page.

Latest updates to the SRA737 Combo with Gem/Cisplatin: Advanced Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record for the SRA737 cancer trial is displayed with its design, eligibility criteria, treatment arms, locations, outcomes, and record dates. It also includes the study protocol and statistical analysis plan.SummaryDifference65%

- Check18 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2, while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH’s website transition and says that “Super Intelligence” is replacing “Artificial Intelligence” in some agency content. It appears above the 403 error page.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2; the page remains a 403 error page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe Study record page now displays a 403 Forbidden error (403 page) instead of showing the study details and documents. This indicates access to the NCT02797977 record is blocked.SummaryDifference19%

Stay in the know with updates to SRA737 Combo with Gem/Cisplatin: Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SRA737 Combo with Gem/Cisplatin: Advanced Cancer Clinical Trial page.